Integrity Implant System Post Market Clinical Follow-Up Study
← catalyst calendarNCT06741527 · readout ≤ 315 d
Sponsored by Anika Therapeutics, Inc. (industry) · ANIK — their whole pipeline →.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
150estimated
Sites
9
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-02-01 | actual | When the study began enrolling |
| Primary completion | Jun 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Oct 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2024-12-19 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-24 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Rotator Cuff Tears of the Shoulder
Intervention
- Device: Integrity Implant System
Primary outcome
what the primary-completion date above is the date OFRe-tear rate after rotator cuff augmentation
measured 12 months postoperatively
Permalink · ANIK's whole pipeline · Catalyst calendar · Every registered study · What changed